Literature DB >> 25116101

Antibodies as natural adjuvants.

Birgitta Heyman1.   

Abstract

Antibodies in complex with specific antigen can dramatically change the antibody response to this antigen. Depending on antibody class and type of antigen, >99 % suppression or >100-fold enhancement of the response can take place. IgM and IgG3 are efficient enhancers and operate via the complement system. In contrast, IgG1, IgG2a, and IgG2b enhance antibody and CD4(+) T cell responses to protein antigens via activating Fcγ-receptors. IgE also enhances antibody and CD4(+) T cell responses to small proteins but uses the low-affinity receptor for IgE, CD23. Most likely, IgM and IgG3 work by increasing the effective concentration of antigen on follicular dendritic cells in splenic follicles. IgG1, IgG2a, IgG2b, and IgE probably enhance antibody responses by increasing antigen presentation by dendritic cells to T helper cells. IgG antibodies of all subclasses have a dual effect, and suppress antibody responses to particulate antigens such as erythrocytes. This capacity is used in the clinic to prevent immunization of Rhesus-negative women to Rhesus-positive fetal erythrocytes acquired via transplacental hemorrage. IgG-mediated suppression in mouse models can take place in the absence of Fcγ-receptors and complement and to date no knock-out mouse strain has been found where suppression is abrogated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25116101     DOI: 10.1007/978-3-319-07911-0_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  17 in total

1.  Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice.

Authors:  David R Gruber; Amanda L Richards; Heather L Howie; Ariel M Hay; Jenna N Lebedev; Xiaohong Wang; James C Zimring; Krystalyn E Hudson
Journal:  Blood Adv       Date:  2020-04-14

2.  Immunoglobulin G structure and rheumatoid factor epitopes.

Authors:  Sheila Lefoli Maibom-Thomsen; Nicole Hartwig Trier; Bettina Eide Holm; Kirsten Beth Hansen; Morten Ib Rasmussen; Anna Chailyan; Paolo Marcatili; Peter Højrup; Gunnar Houen
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

3.  A Restricted Role for FcγR in the Regulation of Adaptive Immunity.

Authors:  Marieke F Fransen; Hreinn Benonisson; Wendy W van Maren; Heng Sheng Sow; Cor Breukel; Margot M Linssen; Jill W C Claassens; Conny Brouwers; Jos van der Kaa; Marcel Camps; Jan Willem Kleinovink; Kelly K Vonk; Sandra van Heiningen; Ngaisah Klar; Lianne van Beek; Vanessa van Harmelen; Lucia Daxinger; Kutty S Nandakumar; Rikard Holmdahl; Chris Coward; Qingshun Lin; Sachiko Hirose; Daniela Salvatori; Thorbald van Hall; Cees van Kooten; Piero Mastroeni; Ferry Ossendorp; J Sjef Verbeek
Journal:  J Immunol       Date:  2018-03-09       Impact factor: 5.422

4.  Therapeutic Antibodies: An Overview.

Authors:  Gunnar Houen
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.

Authors:  Jennifer Lambour; Mar Naranjo-Gomez; Marc Piechaczyk; Mireia Pelegrin
Journal:  Emerg Microbes Infect       Date:  2016-08-17       Impact factor: 7.163

Review 6.  B Cell Intrinsic Mechanisms Constraining IgE Memory.

Authors:  Brice Laffleur; Orianne Debeaupuis; Zeinab Dalloul; Michel Cogné
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

7.  Mice Immunized with IgG Anti-Sheep Red Blood Cells (SRBC) Together With SRBC Have a Suppressed Anti-SRBC Antibody Response but Generate Germinal Centers and Anti-IgG Antibodies in Response to the Passively Administered IgG.

Authors:  Joakim J E Bergström; Birgitta Heyman
Journal:  Front Immunol       Date:  2017-08-02       Impact factor: 7.561

8.  Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.

Authors:  Wenlan Alex Chen; Jinjin Zhang; Katie M Hall; Carol B Martin; Serguei Kisselev; Emily J Dasen; Nicholas N Vahanian; Charles J Link; Brian K Martin
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

9.  Bromodomain and extraterminal (BET) protein inhibition of IgG/IgE production in murine B cells is counter-balanced by a strong Th2 bias.

Authors:  Zeinab Dalloul; Marie Best; Pauline Chenuet; Iman Dalloul; Sandrine Le Noir; Dieudonnée Togbé; Mylène Gador; Bernhard Ryffel; Valerie Fj Quesniaux; Yolla El Makhour; François Boyer; Jean-Claude Aldigier; Jeanne Cook-Moreau; Nicolas Fazilleau; Michel Cogné
Journal:  Clin Transl Immunology       Date:  2021-05-30

10.  IgG Suppresses Antibody Responses in Mice Lacking C1q, C3, Complement Receptors 1 and 2, or IgG Fc-Receptors.

Authors:  Joakim J E Bergström; Birgitta Heyman
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.